| Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study K Le Blanc, F Frassoni, L Ball, F Locatelli, H Roelofs, I Lewis, E Lanino, ... The Lancet 371 (9624), 1579-1586, 2008 | 3131 | 2008 |
| Outcome of cord-blood transplantation from related and unrelated donors E Gluckman, V Rocha, A Boyer-Chammard, F Locatelli, W Arcese, ... New England Journal of Medicine 337 (6), 373-381, 1997 | 1742 | 1997 |
| Oxidative stress in end‐stage renal disease: an emerging threat to patient outcome F Locatelli, B Canaud, KU Eckardt, P Stenvinkel, C Wanner, C Zoccali Nephrology Dialysis Transplantation 18 (7), 1272-1280, 2003 | 1056 | 2003 |
| Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia V Rocha, J Cornish, EL Sievers, A Filipovich, F Locatelli, C Peters, ... Blood, The Journal of the American Society of Hematology 97 (10), 2962-2971, 2001 | 1016 | 2001 |
| Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the … V Conter, CR Bartram, MG Valsecchi, A Schrauder, R Panzer-Grümayer, ... Blood, The Journal of the American Society of Hematology 115 (16), 3206-3214, 2010 | 949 | 2010 |
| Human bone marrow–derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms ME Bernardo, N Zaffaroni, F Novara, AM Cometa, MA Avanzini, A Moretta, ... Cancer research 67 (19), 9142-9149, 2007 | 946 | 2007 |
| Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a … R Maccario, M Podesta, A Moretta, A Cometa, P Comoli, D Montagna, ... Haematologica 90 (4), 516-525, 2005 | 851 | 2005 |
| Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors S Giebel, F Locatelli, T Lamparelli, A Velardi, S Davies, G Frumento, ... Blood 102 (3), 814-819, 2003 | 718 | 2003 |
| Cotransplantation of ex vivo–expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell … LM Ball, ME Bernardo, H Roelofs, A Lankester, A Cometa, RM Egeler, ... Blood, The Journal of the American Society of Hematology 110 (7), 2764-2767, 2007 | 694 | 2007 |
| International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium AC Harris, R Young, S Devine, WJ Hogan, F Ayuk, U Bunworasate, ... Biology of Blood and Marrow Transplantation 22 (1), 4-10, 2016 | 678 | 2016 |
| Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease R Ciccocioppo, ME Bernardo, A Sgarella, R Maccario, MA Avanzini, ... Gut 60 (6), 788-798, 2011 | 676 | 2011 |
| Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial C Pozzi, S Andrulli, L Del Vecchio, P Melis, GB Fogazzi, P Altieri, ... Journal of the American Society of Nephrology 15 (1), 157-163, 2004 | 662 | 2004 |
| Phase I/phase II study of blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia A von Stackelberg, F Locatelli, G Zugmaier, R Handgretinger, TM Trippett, ... Journal of Clinical Oncology 34 (36), 4381-4389, 2016 | 593 | 2016 |
| Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases CM Niemeyer, M Arico, G Basso, A Biondi, AC Rajnoldi, U Creutzig, ... Blood, The Journal of the American Society of Hematology 89 (10), 3534-3543, 1997 | 555 | 1997 |
| A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy C Ponticelli, P Zucchelli, P Passerini, B Cesana, F Locatelli, S Pasquali, ... Kidney international 48 (5), 1600-1604, 1995 | 552 | 1995 |
| Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy RC Atkins, EM Briganti, JB Lewis, LG Hunsicker, G Braden, ... American journal of kidney diseases 45 (2), 281-287, 2005 | 529 | 2005 |
| Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study M Schrappe, MG Valsecchi, CR Bartram, A Schrauder, ... Blood, The Journal of the American Society of Hematology 118 (8), 2077-2084, 2011 | 521 | 2011 |
| Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy T Berl, LG Hunsicker, JB Lewis, MA Pfeffer, JG Porush, JL Rouleau, ... Annals of internal medicine 138 (7), 542-549, 2003 | 519 | 2003 |
| Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement F Locatelli, P Bárány, A Covic, A De Francisco, L Del Vecchio, ... Nephrology Dialysis Transplantation 28 (6), 1346-1359, 2013 | 511 | 2013 |
| Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice E Gluckman, V Rocha, W Arcese, G Michel, G Sanz, KW Chan, ... Experimental hematology 32 (4), 397-407, 2004 | 503 | 2004 |
